Inhibitors of the pd-1/pd-l1 protein/protein interaction

Alexander Dömling

Inhibitors of the pd-1/pd-l1 protein/protein interaction

Alexander Dömling (Inventor)

Drug Design

Research output: Patent

Abstract

The present invention provides novel compounds of formula (I) that are useful as inhibitors of the PD-1/PD-L1 protein/ protein interaction.

Original language	English
Patent number	WO2017118762
Priority date	08/01/2016
Publication status	Published - 13-Jul-2017

Access to Document

https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=WO&NR=2017118762A1&KC=A1&FT=D&ND=3&date=20170713&DB=&locale=en_EP

Handle.net

Persistent link

Cite this

@misc{864920c6cabb49899a391c9f54543ffe,

title = "Inhibitors of the pd-1/pd-l1 protein/protein interaction",

abstract = "The present invention provides novel compounds of formula (I) that are useful as inhibitors of the PD-1/PD-L1 protein/ protein interaction.",

author = "Alexander D{\"o}mling",

year = "2017",

month = jul,

day = "13",

language = "English",

type = "Patent",

note = "WO2017118762",

}

TY - PAT

T1 - Inhibitors of the pd-1/pd-l1 protein/protein interaction

AU - Dömling, Alexander

PY - 2017/7/13

Y1 - 2017/7/13

N2 - The present invention provides novel compounds of formula (I) that are useful as inhibitors of the PD-1/PD-L1 protein/ protein interaction.

AB - The present invention provides novel compounds of formula (I) that are useful as inhibitors of the PD-1/PD-L1 protein/ protein interaction.

M3 - Patent

M1 - WO2017118762

ER -

Inhibitors of the pd-1/pd-l1 protein/protein interaction

Abstract

Access to Document

Handle.net

Fingerprint

Cite this